Hypertension is one of the main morbidity and mortality risk factors in patients with coronavirus disease 2019 (COVID-19). We investigated the association between the C-reactive protein (CRP) to albumin ratio (CAR) and in-hospital mortality in patients with hypertensive COVID-19. A total of 176 patients with hypertension diagnosed with COVID-19 were included in this study. The CAR was compared between survivors and nonsurvivors. Logistic regression analysis was used to detect independent predictors of mortality due to COVID-19 in patients with hypertension. A cutoff value of CAR was obtained for predicting in-hospital death in patients with hypertensive COVID-19. Kaplan-Meier analysis was performed for survival analysis in the study population. The CAR values were significantly higher in nonsurvivors than in survivors with hypertension. Moreover, the CAR was an independent predictor of in-hospital death in patients with hypertensive COVID-19, as shown in multivariable logistic regression analysis. Receiver operating characteristic analysis yielded a cutoff value of 20.75 for the CAR for predicting in-hospital death in patients with hypertension. Kaplan-Meier curve analysis showed that patients with hypertensive COVID-19 with a CAR value of ≥20.75 had a higher incidence of in-hospital death. The CAR might be used as an independent predictor of in-hospital mortality in patients with hypertensive COVID-19.
FuJKongJWangW, et al.The clinical implication of dynamic neutrophil to lymphocyte ratio and D-dimer in COVID-19: A retrospective study in Suzhou China. Thrombosis research2020;192:3–8.
2.
EmamiAJavanmardiFPirbonyehN, et al.Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis. Archives of academic emergency medicine2020;8:e35.
ZhouPYangXLWangXG, et al.A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270–3.
5.
HuangSWangJLiuF, et al.COVID-19 patients with hypertension have more severe disease: a multicenter retrospective observational study. Hypertension Research2020;43:824–31.
6.
GlowackaIBertramSHerzogP, et al.Differential downregulation of ACE2 by the spike proteins of severe acute respiratory syndrome coronavirus and human coronavirus NL63. Journal of virology2010;84:1198–205.
7.
ZhengZPengFXuB, et al.Risk factors of critical & mortal COVID-19 cases: A systematic literature review and meta-analysis. Journal of Infection2020;81:e16–e25.
8.
HageF. C-reactive protein and hypertension. Journal of human hypertension. 2014;28:410–5.
9.
DaneshJCollinsRApplebyP, et al.Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. Jama. 1998;279:1477–82.
10.
GreselePDeckmynHHuybrechtsE, et al.Serum albumin enhances the impairment of platelet aggregation with thromboxane synthase inhibition by increasing the formation of prostaglandin D2. Biochemical pharmacology. 1984;33:2083–2088.
11.
KayapinarOOzdeCKayaA. Relationship between the reciprocal change in inflammation-related biomarkers (Fibrinogen-to-Albumin and hsCRP-to-Albumin ratios) and the presence and severity of coronary slow flow. Clinical and Applied Thrombosis/Hemostasis. 2019; 25:1–10.
12.
QuispeÁLiX-MYiH.Comparison and relationship of thyroid hormones, IL-6, IL-10 and albumin as mortality predictors in case-mix critically ill patients. Cytokine2016; 81:94–100.
13.
DevranÖKarakurtZAdıgüzelN, et al.C-reactive protein as a predictor of mortality in patients affected with severe sepsis in intensive care unit. Multidisciplinary respiratory medicine2012;7:1–6.
14.
ZhangJWangXJiaX, et al.Risk factors for disease severity, unimprovement, and mortality of COVID-19 patients in Wuhan, China. Clinical Microbiology and Infection. 2020;26:767–72.
15.
CellinaMOrsiMPittinoCV, et al.Chest computed tomography findings of COVID-19 pneumonia: Pictorial essay with literature review. Japanese journal of radiology. 2020;38:1012–9.
WuCChenXCaiY, et al.Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA internal medicine. 2020;180:934–43.
18.
WangBLiRLuZ, et al.Does comorbidity increase the risk of patients with COVID-19: evidence from meta-analysis. Aging (Albany NY). 2020;12:6049.
19.
WangDHuBHuC, et al.Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. Jama2020;323:1061–9.
20.
PatelSKVelkoskaEFreemanM, et al.From gene to protein—experimental and clinical studies of ACE2 in blood pressure control and arterial hypertension. Frontiers in physiology. 2014;5:227.
21.
PintoBGOliveiraAESinghY, et al.ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. The Journal of infectious diseases. 2020;222:556–63.
22.
ZhangPZhuLCaiJ, et al.Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19. Circulation research. 2020;126:1671–81.
23.
SelçukMÇınarTKeskinM, et al.Is the use of ACE inb/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?Clinical and Experimental Hypertension. 2020;42:738–42.
24.
OparilSSchmiederRE. New approaches in the treatment of hypertension. Circulation research. 2015;116:1074–95.
25.
DhaunNWebbDJ. Endothelins in cardiovascular biology and therapeutics. Nature Reviews Cardiology2019;16:491–502.
26.
SolerMJBarriosCOlivaR, et al.Pharmacologic modulation of ACE2 expression. Current hypertension reports. 2008;10:410–4.
27.
RidkerPMRifaiNRoseL, et al.Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. New England journal of medicine. 2002;347:1557–65.
28.
MikhailidisDGanotakisE. Plasma albumin and platelet function: relevance to atherogenesis and thrombosis. Platelets. 1996;7:125–37.
29.
GanotakisESVrentzosGEGaziIF, et al.Fibrinogen, lipoprotein (a), albumin and bilirubin (FLAB) levels and cardiovascular risk calculated using the Framingham equation. in vivo. 2007; 21:685–94.
30.
KlokFKruipMVan der MeerN, et al.Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thrombosis research. 2020;191:145–7.
31.
OhTKSongI-ALeeJH. Clinical usefulness of C-reactive protein to albumin ratio in predicting 30-day mortality in critically ill patients: A retrospective analysis. Scientific reports. 2018; 8:1–6.
32.
LiXXuSYuM, et al.Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan. Journal of Allergy and Clinical Immunology2020;146:110–118.
33.
BergstromJLindholmB. Malnutrition, cardiac disease, and mortality: an integrated point of view. American journal of kidney diseases. 1998;32:834–41.
34.
FanZFanKGongY, et al.The CRP/albumin ratio predicts survival and monitors chemotherapeutic effectiveness in patients with advanced pancreatic cancer. Cancer management and research. 2019;11:8781–8.
35.
KarabağYÇağdaşMRencuzogullariI, et al.Relationship between C-reactive protein/albumin ratio and coronary artery disease severity in patients with stable angina pectoris. Journal of clinical laboratory analysis. 2018;32:e22457.
36.
KarabağYÇağdaşMRencuzogullariI, et al.Usefulness of The C-Reactive Protein/Albumin Ratio for Predicting No-Reflow in ST-elevation myocardial infarction treated with primary percutaneous coronary intervention. European journal of clinical investigation. 2018;48:e12928.
37.
KarakoyunIColakATurkenM, et al.Diagnostic utility of C-reactive protein to albumin ratio as an early warning sign in hospitalized severe COVID-19 patients. International immunopharmacology. 2021;91:107285.
38.
GüneyBÇTaştanYÖDoğantekinB, et al.Predictive value of CAR for In-Hospital Mortality in Patients with COVID-19 Pneumonia: A Retrospective Cohort Study. Archives of medical research. 2021;0:35.
39.
TamaraATahaparyDL. Obesity as a predictor for a poor prognosis of COVID-19: A systematic review. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2020;14:655–59.
40.
MosliRHMosliHH. Obesity and morbid obesity associated with higher odds of hypoalbuminemia in adults without liver disease or renal failure. Diabetes, metabolic syndrome and obesity: targets and therapy. 2017;10:467–72.
41.
ZimmermanRFrohlichE. Stress and hypertension. Journal of hypertension Supplement: official journal of the International Society of Hypertension1990;8:103–7.
